Skip to Main Content
Legislation Search

S. 4311: Consumer Protection Remedies Act of 2026

This bill, known as the Consumer Protection Remedies Act of 2026, aims to amend the Federal Trade Commission (FTC) Act to enhance the tools available to the FTC for consumer protection. The main aspects of the bill include:

Expanded Enforcement Authority

The bill modifies the existing provisions of the FTC Act, allowing the Commission to take action against individuals or corporations that have violated consumer protection laws. It broadens the grounds for taking enforcement action by specifying that the FTC can act when a violation has occurred, is occurring, or is about to occur.

Equitable Remedies

The bill introduces new measures that give the FTC the authority to seek equitable remedies in court. These include:

  • Restitution: Consumers can be awarded money back for losses caused by the violation.
  • Contract Rescission and Reformation: Courts can cancel or modify contracts that are harmful to consumers.
  • Disgorgement: Companies may be required to return profits gained unjustly from unlawful actions.

Limitations on Claims

Relief in cases brought under this act is subject to limitations. The FTC can only pursue claims for violations that occurred within the 10 years preceding the filing of a lawsuit. Additionally, if a person or entity against whom relief is sought is located outside the United States, that time does not count towards this 10-year limitation.

Conforming Amendments

The bill includes technical amendments to ensure consistency within the FTC Act. These adjustments reflect the changes and clarifications made through this legislation.

Applicability

The provisions of this bill would apply to any actions or proceedings that commence after the bill is enacted.

Relevant Companies

None found.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

6 bill sponsors

Actions

2 actions

Date Action
Apr. 15, 2026 Introduced in Senate
Apr. 15, 2026 Read twice and referred to the Committee on Commerce, Science, and Transportation.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.